Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,038 signal articles · 349 in last 24h · 114,007 total before filter · latest 40m ago
349last 24h
1938last 7d
317● bullish (7d)
169● bearish (7d)
205publishers
AllMacro322Earnings1003M&A99Regulatory24Product18Analyst18
✕ clear all filtersticker: INFYSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Crocs inks AI tech deal
Retail Dive1d agoneutral
Crocs inks AI tech deal

The footwear company is working to modernize its core business and IT systems in order to simplify operations and reduce costs.

Bloomberg8d agoneutral
Microsoft Opens Fourth Data Center Region in India for Azure

(Bloomberg) -- Microsoft Corp. announced its fourth data center region in India is up and running as part of a broader $20.5 billion investment in the country to build out cloud and artificial intelligence capabilities. Most Read from BloombergIran Says Agreement on Hormuz Shipping Reached With OmanGoogle AI Veterans Depart During Seismic Leadership ShiftMicrosoft’s AI Sales Mostly Come From OpenAI, Disclosures ShowMajor Hedge Funds Targeted in Wave of Attempted CyberattacksWhy Do Data Centers U

Infosys (NSEI:INFY) Stock Fair Value Falls After Analysts Cut Targets On Weaker Outlook
Simply Wall St.13d agobearish
Infosys (NSEI:INFY) Stock Fair Value Falls After Analysts Cut Targets On Weaker Outlook

Infosys now sits on a lower implied fair value, with the updated price target in the model moving from about ₹1,395.13 to roughly ₹1,199.02, a cut of around 14%. This shift lines up with more cautious research coverage after the Q1 miss and guidance reset, as analysts weigh weaker organic growth, pricing pressure, and AI related productivity effects against the current valuation. As you read on, you will see how these target changes fit into the broader Infosys story and what to watch as the...

Infosys Q1 Earnings Call Highlights
MarketBeat21d agoneutral
Infosys Q1 Earnings Call Highlights

Infosys (NYSE:INFY) announced a planned CEO transition alongside first-quarter results that showed modest constant-currency revenue growth, strong large-deal bookings and accelerating artificial intelligence-related revenue, while management lowered the top end of its full-year revenue growth outloo

Bloomberg22d agobearish
Infosys Cuts Revenue Forecast as IT Service Demand Remains Muted

(Bloomberg) -- Infosys Ltd. cut the upper end of its sales growth outlook as global clients slow down technology spending at a time of elevated interest rates and geopolitical conflicts.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump’s 100% Generic Drug Duty Threatens US Low-Cost SupplyAlphabet’s $205 Billion Spending Target Fuels

Bloomberg31d agobearish
Software Stocks Sink as IBM Miss Delivers ‘Devastating Blow’

(Bloomberg) -- Shares of software and IT services companies plunged Tuesday after International Business Machines Corp. reported preliminary results that missed analyst expectations, reigniting questions over the sector’s prospects.Most Read from BloombergUS Hits Iran With Strikes, Blockade as Trump Plans Hormuz ChargeLindsey Graham, Senate Hawk Turned Trump Ally, Dies at 71Trump Embraces Australian Retirement System Backed by Larry FinkDisney Exiting Streaming Could Spur 40% Rally: Wells FargoO

Infosys Limited (INFY) Partners with Sentara To Enable AI Integration and Use in Hospitals
Insider Monkey36d agoneutral
Infosys Limited (INFY) Partners with Sentara To Enable AI Integration and Use in Hospitals

Infosys Limited (NYSE:INFY) is one of the best beaten-down technology stocks to buy now. On June 24, Infosys Ltd (NYSE: INFY) entered into a strategic collaboration with Sentara to build a foundation for AI development across hospital operations, IT, and clinical support. The ultimate goal is to enhance efficiency, support clinicians, and improve the experiences […]